Mouse Mammary Tumor Virus (MMTV), a retrovirus that exploits the immune system: Genetics of susceptibility to MMTV infection

Medicina

Volumn 57, Issue SUPPL. 2, 1997, Pages 34-42

  Ross, Susan R ^a   Dzuris, John L ^a   Golovkina, Tatyana V ^a   Clemmons, Wayne C ^a   Van Den Hoogen, Bernadette ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Mammary tumor; MMTV; Superantigen

Indexed keywords

NUCLEOTIDE;

ANIMAL; ARTICLE; B LYMPHOCYTE; C57BL MOUSE; CARBOHYDRATE ANALYSIS; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; MOUSE; MOUSE MAMMARY TUMOR ONCOVIRUS; RETROVIRUS; RETROVIRUS INFECTION; T LYMPHOCYTE; VIRUS DNA CELL DNA INTERACTION; VIRUS INFECTION;

ANIMALS; B-LYMPHOCYTES; CARBOHYDRATE SEQUENCE; GAMMARETROVIRUS; GENETIC PREDISPOSITION TO DISEASE; MAMMARY TUMOR VIRUS, MOUSE; MICE; MICE, INBRED C57BL; NUCLEOTIDES; RETROVIRIDAE INFECTIONS; T-LYMPHOCYTES; TUMOR VIRUS INFECTIONS; VIRUS INTEGRATION;

EID: 0031317784     PISSN: 00257680     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Duesberg PH, Cardiff RD. Structural relationships between the RNA of mammary tumor virus and those of other RNA tumor viruses. Virology 1968; 49:92-101.
2. Bittner JJ. Some possible effects of nursing on the mammary gland tumor incidence in mice. Science 1936; 84: 162.
3. Heston WE, Deringer MK, Andervont HB. Gene-milk agent relationship in mammary tumor development. J Natl Cancer Inst 1945; 5: 289-307.
4. Yamamoto K. Steroid receptor regulated transcription of specific genes and gene networks. Ann Rev Genet 1985; 19: 209-52.
5. Peters G, Lee A, Dickson C. Concerted activation of two potential proto-oncogenes in carcinomas induced by mouse mammary tumour virus. Nature 1986; 320: 628-31.
6. Fung Y-KT, Shackleford G, Brown A, Sanders G, Varmus H. Nucleotide sequence and expression in vitro of cDNA dericed from mRNA of int-1, a provirally activated mouse mammary oncogene. Mol Cell Biol 1985; 5: 3337-44.
7. Moore R, Casey G, Brookes S, Dixon M, Peters G, Dickson C. Sequence, topography and protein coding potential of mouse int-2: a putative oncogene activated by mouse mammary tumour virus. EMBO J 1986; 5: 919-24.
8. Nusse R, Van Ooyen A, Cox D, Fung Y, Varmus H. Mode of proviral activation of a putative mammary oncogene (int1) on mouse chromosome 15. Nature 1984; 307: 131-6.
9. Dickson C, Smith R, Brookes S, Peters G. Tumorigenesis by mouse mammary tumor virus: proviral activation of a cellular gene in the common integration region int-2. Cell 1984; 37: 529-36.
10. Peters G. Inappropriate expression of growth factor genes in tumors induced by mouse mammary tumor virus. Sem in Virol 1991; 2: 319-28.
11. Meyers SL, Dudley JP. Sequence analysis of the int-2/fgf-3 gene in aggressive human breast carcinomas. Mol Care 1992; 6: 243-51.
12. Bentvelzen P, Hilgers J. Murine mammary tumor virus. In: Viral oncology. G. Klein (ed) New York: Raven Press, 1980.
13. Michalides R, van Ooyen A, Nusse R. Mouse mammary tumor virus expression and mammary tumor development. Curr Topics Micro Immunol 1983; 106: 57-78.
14. Golovkina TV, Chervonsky A, Dudley JP, Ross SR. Transgenic mouse mammary tumor virus superantigen expression prevents viral infection. Cell 1992; 69: 637-45.
15. Held W, Waanders G, Shakhov AN, Scarpellino L, Acha-Orbea H, Robson-MacDonald H. Superantigen induced immune stimulation amplifies mouse mammary tumor virus infection and allows virus transmission. Cell 1993; 529-40.
16. Choi Y, Kappler JW, Marrack P. A super antigen encoded in the open reading frame of the 3′ long terminal repeat of the mouse mammary tumor virus. Nature 1991; 350: 203-7.
17. Acha-Orbea H, Shakhov AN, Scarpelhno L, Kolb E, Muller V, Vessaz-Shaw A, et al. Clonal deletion of vb 14-bearing T cells in mice transgenic for mammary tumor virus. Nature 1991; 350: 207-10.
18. Marrack P, Kushnir E, Kappier J. A maternally inherited superantigen encoded by mammary tumor virus. Nature 1991; 349: 524-6.
19. Frankel WN, Rudy C, Coffin JM, Huber BT. Linkage of Mls genes to endogenous mammary tumour viruses of inbred mice. Nature 1991; 349: 526-8.
20. Woodland DL, Happ MP, Gollob KJ, Palmer E. An endogenous retrovirus mediating deletion of αβ T cells? Nature 1991; 349: 529-30.
21. Dyson PJ, Knight AM, Fairchild S, Simpson E, Tomonari K. Genes encoding ligands for deletion of VB11 T cells cosegretate with mammary tumour virus genomes. Nature 1991; 349: 531-2.
22. Beutner U, Draus E, Kitamura D, Rajewsky K, Huber BT. B cells are essential for murine mammary tumor virus transmission, but not for presentation of endogenous superantigens. J Exp Med 1994; 179: 1457-66.
23. Wrona T, Dudley JP. Major histocompatibility complex class II I-E independent transmission of C3H mouse mammary tumor virus. J Virol 1996; 70: 1246-9.
24. Michalides R, van Deemter L, Nusse R, van Nie R. Identification of the Mtv-2 gene responsible for early appearance of mammary tumors in the GR mouse by nucleic acid hybridization. Proc Natl Acad Sci USA 1978; 75: 2368-72.
25. Golovkina TV, Prakash O, Gotovkina TV. Endogenous mouse mammary tumor virus Mtv-17 is involved in Mtv-2-induced tumorigenesis in GR mice. Virol 1996; 218: 14-22.
26. Ross SR, Golovkina TV. The role of endogenous Mtvs in resistance to MMTV-induced mammary tumors. In: Tomonari K, (ed). Viral Superantigens. Boca Raton, FL: CRC Press, 1997; 89-99.
27. Golovkina TV, Piazzon I, Nepomnaschy I, Buggiano V, de Olano Vela M, Ross SR. Generation of a tumorigenic milk-borne mouse mammary tumor virus by recombination between endogenous and exogenous viruses. J Virol 1997; 71: 3895-903.
28. Henrard D, Ross SR. Endogenous mouse mammary tumor virus is expressed in several organs in addition to the lactating mammary gland. J Virol 1988; 62: 3046-9.
29. Choi YC, Henrard DH, Lee I, Ross SR. The mouse mammary tumor virus long terminal repeat directs expression in epithelial and lymphoid cells of different tissues in transgenic mice. J Virol 1987; 61: 3013-9.
30. Ross SR, Hsu C-L, Choi Y, Mok E, Dudley JP. Negative regulation in correct tissue-specific expression of mouse mammary tumor virus in transgenic mice. Mol and Cell Biol 1990; 10: 5822-9.
31. Dzuris J, Golovkina T, Ross SR, Both T and B cells shed infectious MMTV. J Virol 1997; in press
32. Nandi S, McGrath CM. Mammary neoplasia in mice. Adv Canc Res 1973; 17: 353-414.
33. Goiovkina TV, Dudley JP, Ross SR. Sag activity is needed for mouse mammary tumor virus spread within the mammary gland. Submitted.
34. Golovkina TV, Chervonsky A, Prescott JA, Janeway CA, Ross SR. The mouse mammary tumor virus envelope gene product is required for superantigen presentation to T cells. J Exp Med 1994; 179: 439-46.
35. Nabarra B, Desaymard C, Wache A-C, Papiernik M. Mouse mammary tumor virus production by thymic epithelial cells in vivo. Eur J Immunol 1996; 26: 2724-30.
36. Ross SR. MMTV and the immune system. Adv Pharm 1996; 39: 21-46.
37. Muhlbock O, Dux A. MTV-variants and histocompatibility. In: Mouriquand J, (ed). Fundamental research on mammary tumours. Paris: INSERM, 1972; 11-20.
38. Dux A. Genetic aspects in the genesis of mammary cancer. In: Emmelot P, Bentvelzen P, (eds). RNA Viruses and Host Genome in Oncogenesis. Amsterdam: North-Holland Publ., 1972; 301-8.
39. Simpson E, Dyson PJ, Knight AM, Robinson PJ, Elliott JI, Altmann DM. T-cell receptor repertoire selection by mouse mammary tumor viruses and MHC molecules. Immunol Rev 1993; 131: 93-115.
40. Pucillo C, Cepeda R, Hodes RJ. Expression of a MHC Class II transgene determines superantigenicity and susceptibility to mouse mammary tumor virus infection. J Exp Med 1993; 178: 1441-5.
41. Golovkina TV, Dzuris JL, van den Hoogen B, Jaffe AB, Wright PC, Cofer SM, Ross SR. A novel membrane protein is a mouse mammary tumor virus receptor. (Submitted for publication).